Isosorbide Mononitrato Doc Generici (Isosorbide 5 Mononitrate)

After oral intake, isosorbide mononitrate is converted to nitric oxide. The nitric oxide activates guanylate cyclase, increasing cyclic GMP levels in vascular smooth muscle, causing vasodilation that lowers both preload and afterload, thereby decreasing myocardial oxygen demand.

The appropriate dose is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Patients should follow the dosage instructions provided by their healthcare professional.

Safety data in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Isosorbide mononitrate provides sustained nitrate‑mediated vasodilation, unlike short‑acting nitroglycerin which is used for acute relief. Compared with beta‑blockers, it directly reduces preload and afterload without affecting heart rate, making it a useful adjunct or alternative in patients who cannot tolerate beta‑blockade.

Store the product at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, direct sunlight and excessive heat to maintain stability and potency.

The medication is taken orally. Patients should swallow the tablet whole with a glass of water, preferably at the same times each day, and should not crush or chew the tablet unless specifically instructed by a healthcare professional.

The most serious adverse events include severe hypotension, syncope, life‑threatening arrhythmias, myocardial infarction in vulnerable patients, and rare allergic reactions such as anaphylaxis. Prompt medical attention is required if any of these occur.

Patients with known severe hypotension, recent use of phosphodiesterase‑5 inhibitors, or those who are hypersensitive to nitrates should avoid this medication. It is also contraindicated in patients with certain forms of cardiogenic shock or uncontrolled heart failure without medical supervision.